58
Views
6
CrossRef citations to date
0
Altmetric
Articles

Estimating the Dose-Response Pattern by the Maximal Contrast Type Test Approach

Pages 40-53 | Received 01 Nov 2008, Published online: 01 Jan 2012
 

Abstract

In a phase II clinical trial it is simultaneously required to prove a drug is truly effective by showing a monotone dose-response relationship and also to obtain information on the recommended dose for the ordinary clinical treatments. Then the multiple comparisons of the interested dose-response patterns are more preferable than an overall testing of the null hypothesis or a fitting of a particular parametric model. In this article the maximal accumulated t statistic (max acc. t-test) proposed for the monotone hypothesis testing is compared with other maximal contrast type tests and shown to be useful also for estimating the dose-response pattern. It is even remarkable that the effect of adding other monotone contrasts to the basic contrasts of max acc. t is so small. The simultaneous lower bounds obtained by the inversion of max acc. t is also shown to be useful for this purpose and has some advantage in giving the lower confidence bound for the mean difference of the estimated optimal dose against the basic dose level. In particular a new formula is obtained in this article for extending the basic lower bounds of max acc. t to all the monotone contrasts by the unique and positive linear combination.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.